Recruiting
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
NCT07599813
- Conditions
- Atopic, Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
- Locations
-
- AllerVie Clinical Research Birmingham, Alabama, United States
- Cahaba Dermatology and Skin Health Center Birmingham, Alabama, United States
- Saguaro Dermatology Associates Phoenix, Arizona, United States
- Dermatology Trial Associates, Inc Bryant, Arkansas, United States